| Financial Year |
March 31 2023 |
| Monetary Funds |
3,731,621,851.08 |
| Held-for-trading Financial Assets |
874,865,280.92 |
| Notes Receivable |
12,750,000.00 |
| Accounts Receivable |
161,410,306.16 |
| Advances to Suppliers |
85,321,116.24 |
| Other Receivables |
7,541,877.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
987,235,339.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
134,287,614.71 |
| Total Current Assets |
5,995,033,386.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
162,768,328.91 |
| Investment Properties |
-- |
| Fixed Assetes |
1,349,953,511.16 |
| Under-construction Projects |
19,135,171.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
265,490,823.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
426,105.25 |
| Deferred Income Tax Assets |
64,818,232.58 |
| Other Non-Current Assets |
9,430,859.80 |
| Sub-Total of Non-Current Assets |
2,273,044,182.10 |
| Total Assets |
8,268,077,568.57 |
| Short-Term Loans |
389,124,177.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
75,150,000.00 |
| Accounts Payable |
288,041,526.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,865,706.32 |
| Taxes Payable |
81,227,602.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
121,443,068.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,668,951.71 |
| Other Current Liabilities |
231,621,880.88 |
| Sub-Total of Current Liabilities |
1,325,697,737.34 |
| Long-term Loans |
-- |
| Bonds Payable |
1,311,801,460.33 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,912,776.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,432,202,120.37 |
| Total Liabilities |
2,757,899,857.71 |
| Paid-In Capital(Or Share Stock) |
507,002,312.00 |
| Capital Surplus |
1,546,549,023.72 |
| Surplus Reserve |
253,500,000.00 |
| LESS:Treasury Stock |
56,221,294.58 |
| Undistributed Profits |
3,041,470,126.15 |
| Minority Stockholder's Interest |
2,808,863.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,507,368,846.88 |
| Owner's Equity（Stockholder's Equity） |
5,510,177,710.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,268,077,568.57 |
